Abstract:Abstract Background Synovial tissue fibrosis is common in advanced OA with features including the presence of stress fiber-positive myofibroblasts and deposition of cross-linked collagen type-I. Proteoglycan-4 (PRG4) is a mucinous glycoprotein secreted by synovial fibroblasts and is a major component of synovial fluid. PRG4 is a ligand of the CD44 receptor. Our objective was to examine the role of PRG4-CD44 interaction in regulating synovial tissue fibrosis in vitro and in vivo. Methods OA synoviocytes were treated with TGF-β ± PRG4 for 24 h and α-SMA content was determined using immunofluorescence. Rhodamine-labeled rhPRG4 was incubated with OA synoviocytes ± anti-CD44 or isotype control antibodies and cellular uptake of rhPRG4 was determined following a 30-min incubation and α-SMA expression following a 24-h incubation. HEK-TGF-β cells were treated with TGF-β ± rhPRG4 and Smad3 phosphorylation was determined using immunofluorescence and TGF-β/Smad pathway activation was determined colorimetrically. We probed for stress fibers and focal adhesions (FAs) in TGF-β-treated murine fibroblasts and fibroblast migration was quantified ± rhPRG4. Synovial expression of fibrotic markers: α-SMA, collagen type-I, and PLOD2 in Prg4 gene-trap ( Prg4 GT ) and recombined Prg4 GTR animals were studied at 2 and 9 months of age. Synovial expression of α-SMA and PLOD2 was determined in 2-month-old Prg4 GT/GT & Cd44 −/− and Prg4 GTR/GTR & Cd44 −/− animals. Results PRG4 reduced α-SMA content in OA synoviocytes ( p < 0 . 001 ). rhPRG4 was internalized by OA synoviocytes via CD44 and CD44 neutralization attenuated rhPRG4’s antifibrotic effect ( p < 0 . 05 ). rhPRG4 reduced pSmad3 signal in HEK-TGF-β cells ( p < 0 . 001 ) and TGF-β/Smad pathway activation ( p < 0 . 001 ). rhPRG4 reduced the number of stress fiber-positive myofibroblasts, FAs mean size, and cell migration in TGF-β-treated NIH3T3 fibroblasts ( p < 0 . 05 ). rhPRG4 inhibited fibroblast migration in a macrophage and fibroblast co-culture model without altering active or total TGF-β levels. Synovial tissues of 9-month-old Prg4 GT/GT animals had higher α-SMA, collagen type-I, and PLOD2 ( p < 0 . 001 ) content and Prg4 re-expression reduced these markers ( p < 0 . 01 ). Prg4 re-expression also reduced α-SMA and PLOD2 staining in CD44-deficient mice. Conclusion PRG4 is an endogenous antifibrotic modulator in the joint and its effect on myofibroblast formation is partially mediated by CD44, but CD44 is not required to demonstrate an antifibrotic effect in vivo.

Combination of intermittent hydrostatic pressure linking TGF-β1, TNF-α on modulation of proteoglycan 4 metabolism in rat temporomandibular synovial fibroblasts.

[Involvement of Smad Pathway in Proteoglycan 4 Expression Induced by Hydrostatic Pressure in Temporomandibular Synovial Fibroblasts].

Hydrostatic pressure induces increased production of TGF-β via ERK activation in synovial fibroblasts from rzat temporomandibular joint

Effects of Hydrostatic Pressure on Cytoskeleton and Bmp-2, Tgf-Beta, Sox-9 Production in Rat Temporomandibular Synovial Fibroblasts

The effects of hydrostatic pressure on PRG4 production in rat synovial fibroblasts

Effect of TLR4/MyD88 Signaling Pathway on Expression of IL-1β and TNF-α in Synovial Fibroblasts from Temporomandibular Joint Exposed to Lipopolysaccharide

Pressure and Inflammatory Stimulation Induced Increase of Cadherin-11 is Mediated by PI3K/Akt Pathway in Synovial Fibroblasts from Temporomandibular Joint.

Proteoglycan-4 regulates fibroblast to myofibroblast transition and expression of fibrotic genes in the synovium

Computational and experimental characterizations of the spatiotemporal activity and functional role of TGF-β in the synovial joint

Therapeutic Application of 3B-PEG Injectable Hydrogel/nell-1 Composite System to Temporomandibular Joint Osteoarthritis

Proteoglycan 4 (Lubricin) and Regulation of Xanthine Oxidase in Synovial Macrophage as A Mechanism of Controlling Synovitis

Effects of TNF-α Versus Total Glucosides from Paeony on Functions of Synovial Cells of CIA Rats

Platelet-rich plasma attenuates the severity of joint capsule fibrosis following post-traumatic joint contracture in rats

The effects of different doses of transforming growth factor-β1 on temporomandibular joint osteoarthritis in rabbit model

Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation

Inhibition of HMGB1 Suppresses Inflammation and Catabolism in Temporomandibular Joint Osteoarthritis Via NF-κB Signaling Pathway.

Effect of Different Doses of Transforming Growth Factor-Β1 on Cartilage and Subchondral Bone in Osteoarthritic Temporomandibular Joints

Platelet factor 4 (CXCL4/PF4) upregulates matrix metalloproteinase-2 (MMP-2) in gingival fibroblasts

[Effect of Transforming Growth Factor Β(1) and Insulin-Like Growth Factor-I on Extracelluar Matrix Synthesis of Self-Assembled Constructs of Goat Temporomandibular Joint Disc].

Attenuative Effects of Platelet-Rich Plasma on 30 kDa Fibronectin Fragment-Induced MMP-13 Expression Associated with TLR2 Signaling in Osteoarthritic Chondrocytes and Synovial Fibroblasts

Syndecan-4 inhibition attenuates cartilage degeneration in temporomandibular joint osteoarthritis